reduning: Clinical Trials

4 trials of reduning, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 1 not yet recruiting. 3 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3Unknown 2, Not yet recruiting 1
Phase 41Unknown 1

Follow reduning: new trials by email Literature Review of reduning trials Research Report on reduning

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study on the Efficacy and Safety of Reduning Injection in the Treatment of Chikungunya Fever
Reduning injection, The simulant of Reduning Injection - Chikungunya Fever
Not applicableNot yet recruitingJiangsu Kanion Pharmaceutical Co., Ltd4002025-08-282025-08-17
Clinical Study of Reduning Injection for the Treatment of Influenza in Children
Reduning injection, Oseltamivir phosphate granules - Influenza in Children
Phase 4UnknownChina Academy of Chinese Medical Sciences2402019-12-012019-12-05
A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
Western therapy, Reduning Injection, Reduning Injection plus western therapy - Hand, Foot and Mouth Disease
Not applicableUnknownJiangsu Kanion Pharmaceutical Co., Ltd3602010-05-012010-08-05
A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease
Herbal concentrate-granules plus western therapy, Reduning Injection plus western therapy, Western therapy - Hand, Foot and Mouth Disease
Not applicableUnknownBeijing YouAn Hospital3902010-05-012010-06-17

Conditions studied

Hand, Foot and Mouth Disease (2)  ·  Chikungunya Fever (1)  ·  Mouth Diseases (1)

Sponsors

Jiangsu Kanion Pharmaceutical Co., Ltd (2)  ·  Beijing YouAn Hospital (1)  ·  China Academy of Chinese Medical Sciences (1)

Countries

China (3)

Top investigators

Wei Xiao (1)  ·  Yanming Xie, Study Principal Investigator (1)

Results publications

PMID 27392481, PMID 37474974